WOODCLIFF LAKE, N.J., June 15, 2023 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. ( Nasdaq: EGRX ) ("Eagle" or the "Company") today provided a business update and reiterated its 2023 financial guidance.